Chronic ouabain treatment enhances cardiac myosin ATPase activity in rats. 2008

Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
Department of Physiological Sciences, Federal University of Espirito Santo, Vitória, Espírito Santo, Brazil. ale_padilha@hotmail.com

1. Chronic ouabain administration increases blood pressure and produces a positive inotropic effect. However, the temporal changes capable of affecting both arterial and ventricular pressures and myosin ATPase activity during the induced hypertension have not been determined. 2. The aim of the present study was to investigate the time-course of the induction of hypertension to define when changes occur in Wistar rats treated with 25 mg/kg per day, s.c., ouabain for 3, 7, 15 or 30 days. 3. In anaesthetized rats, diastolic blood pressure increased after 7 days treatment with ouabain and after 15 and 30 days treatment, increases were observed in systolic blood pressure, left ventricular systolic pressure and myosin ATPase activity. After 15 days treatment, heart rate (HR) also increased, but after 30 days treatment HR returned to control levels. However, only after 30 days treatment did the left ventricular positive and negative first derivatives of intraventricular pressure (dP/dt(max) and dP/dt(min), respectively) increase. Increased arterial and left ventricular systolic pressures and myosin ATPase activity observed after 15 days treatment maintained similar levels as those after 30 days treatment. 4. The results suggest that changes in arterial and left ventricular pressures, HR and myosin ATPase activity induced by chronic ouabain treatment are time dependent, increasing after 15 days treatment. After 30 days treatment, the increase in systolic and diastolic arterial and ventricular pressures remained stable, as did inotropism. Normalization of HR after 30 days treatment suggests that during the period from Day 16 to Day 30 ouabain-induced hypertension is dependent, at least in part, on increased sympathetic activity.

UI MeSH Term Description Entries
D008297 Male Males
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D009218 Myosins A diverse superfamily of proteins that function as translocating proteins. They share the common characteristics of being able to bind ACTINS and hydrolyze MgATP. Myosins generally consist of heavy chains which are involved in locomotion, and light chains which are involved in regulation. Within the structure of myosin heavy chain are three domains: the head, the neck and the tail. The head region of the heavy chain contains the actin binding domain and MgATPase domain which provides energy for locomotion. The neck region is involved in binding the light-chains. The tail region provides the anchoring point that maintains the position of the heavy chain. The superfamily of myosins is organized into structural classes based upon the type and arrangement of the subunits they contain. Myosin ATPase,ATPase, Actin-Activated,ATPase, Actomyosin,ATPase, Myosin,Actin-Activated ATPase,Actomyosin ATPase,Actomyosin Adenosinetriphosphatase,Adenosine Triphosphatase, Myosin,Adenosinetriphosphatase, Actomyosin,Adenosinetriphosphatase, Myosin,Myosin,Myosin Adenosinetriphosphatase,ATPase, Actin Activated,Actin Activated ATPase,Myosin Adenosine Triphosphatase
D010042 Ouabain A cardioactive glycoside consisting of rhamnose and ouabagenin, obtained from the seeds of Strophanthus gratus and other plants of the Apocynaceae; used like DIGITALIS. It is commonly used in cell biological studies as an inhibitor of the NA(+)-K(+)-EXCHANGING ATPASE. Acocantherin,G-Strophanthin,Acolongifloroside K,G Strophanthin
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
October 2020, Neuropharmacology,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
January 1975, Recent advances in studies on cardiac structure and metabolism,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
February 1995, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
January 1979, Acta biologica Academiae Scientiarum Hungaricae,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
June 2009, American journal of physiology. Heart and circulatory physiology,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
March 1984, Molecular and cellular endocrinology,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
April 1985, Research communications in chemical pathology and pharmacology,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
May 1968, Circulation research,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
April 2015, Pharmacological reports : PR,
Alessandra S Padilha, and Cleci M Moreira, and Eduardo F Meira, and Fabiana D M Siman, and Ivanita Stefanon, and Dalton V Vassallo
July 1984, Journal of molecular and cellular cardiology,
Copied contents to your clipboard!